NDC 86032-060-01 - Homatropine Methylbromide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86032-060
- Requested NDC
- 86032-060-01
- Package NDCs from labels
- 86032-060-01
- Manufacturer
- Evereen Shanghai Biotechnology Ltd. | Newstarpharm Technology Limited
- Effective date
- 2025-09-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Homatropine Methylbromide | Evereen Shanghai Biotechnology Ltd. | Newstarpharm Technology Limited | 2025-09-19 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86032-060-01 | Homatropine Methylbromide | 50 g in 1 BAG | POWDER | 50 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | KVK-Tech, Inc. | 26d7c90c-5e6b-4bdb-b06f-c76173a01c21 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION | KVK-Tech, Inc. | 9a737416-08e0-4df6-897e-cf9d1b5f0b01 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Genus Lifesciences Inc. | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | PAI Holdings, LLC dba PAI Pharma | 71319a6f-aaf4-4bc5-8b40-a16c6f139be6 | 2026-02-28 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Novel Laboratories, Inc. | 4050ae05-7f1a-48b7-99b9-f8db8aa02741 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Lupin Pharmaceuticals,Inc. | 41ac90b3-f007-4eb2-9d41-ea626ced2017 | 2024-09-12 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Novel Laboratories, Inc. | b203c87c-1108-4eaa-8a57-87be776d8a70 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 68JRS2HC1C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.